Ruyi Xue Selected Research

Gemcitabine

12/2018

BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruyi Xue Research Topics

Disease

12	Neoplasms (Cancer) 02/2024 - 10/2009
12	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2011
3	Non-alcoholic Fatty Liver Disease 12/2023 - 05/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 02/2018 - 01/2009
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 02/2010
2	Fibrosis (Cirrhosis) 10/2022 - 01/2009
2	Thrombosis (Thrombus) 04/2021 - 03/2015
2	Chronic Hepatitis B 07/2011 - 01/2011
1	COVID-19 12/2023
1	Colitis 01/2022
1	Crohn Disease (Crohn's Disease) 01/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021
1	Genomic Instability 01/2021
1	Cholangiocarcinoma 05/2020
1	Acute Coronary Syndrome 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2018
1	Lymphoma (Lymphomas) 12/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Cholestasis 01/2018
1	Inflammation (Inflammations) 03/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Esophageal Squamous Cell Carcinoma 08/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2014
1	Fatty Liver 07/2014
1	Alcoholic Fatty Liver 05/2014
1	Carcinogenesis 03/2013
1	Prostatic Neoplasms (Prostate Cancer) 08/2011
1	Liver Neoplasms (Liver Cancer) 04/2008

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2008
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2015
2	NLR ProteinsIBA 01/2020 - 03/2015
2	Bile Acids and Salts (Bile Acids)IBA 01/2018 - 05/2014
1	SARS-CoV-2 inactivated vaccinesIBA 12/2023
1	Inactivated VaccinesIBA 12/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	UbiquitinIBA 10/2022
1	Carrier Proteins (Binding Protein)IBA 10/2022
1	MicroRNAs (MicroRNA)IBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	tricyclodecane-9-yl-xanthogenateIBA 04/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	InflammasomesIBA 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2021
1	Lamin Type A (Lamin A)IBA 01/2021
1	Immune Checkpoint ProteinsIBA 05/2020
1	LigandsIBA 05/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Gemcitabine FDA Link 12/2018
1	venetoclaxIBA 12/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018
1	Polyamine OxidaseIBA 11/2018
1	EnzymesIBA 11/2018
1	PolyaminesIBA 11/2018
1	Connective Tissue Growth FactorIBA 02/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	estrone sulfotransferaseIBA 01/2018
1	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 04/2016
1	Acetylmuramyl-Alanyl-IsoglutamineIBA 03/2015
1	NucleotidesIBA 03/2015
1	Sorafenib (BAY 43-9006)FDA Link 03/2015
1	Inhibitor of Apoptosis ProteinsIBA 03/2015
1	Docetaxel (Taxotere)FDA Link 08/2014
1	Cisplatin (Platino)FDA LinkGeneric 08/2014
1	Cytochromes c (Cytochrome c)IBA 08/2014
1	Caspase 8 (Caspase-8)IBA 08/2014
1	Caspase 9IBA 08/2014
1	LipopolysaccharidesIBA 07/2014
1	FructoseIBA 07/2014
1	Carbon Tetrachloride (Tetrachloromethane)IBA 06/2014
1	Toll-Like Receptor 2IBA 06/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2014
1	ErbB Receptors (EGF Receptor)IBA 05/2013
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 03/2013
1	Glycoproteins (Glycoprotein)IBA 01/2013
1	Sarcosine (Methylglycine)IBA 08/2011
1	Peptides (Polypeptides)IBA 07/2011
1	CytokinesIBA 01/2011
1	Biotin (Vitamin H)FDA Link 01/2011
1	1-octen-3-olIBA 04/2008
1	n-hexanal (hexanal)IBA 04/2008
1	octaneIBA 04/2008
1	4-sulfophenylmethallyl ether (SPME)IBA 04/2008

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2015
4	Immunotherapy 02/2024 - 01/2022
1	Percutaneous Coronary Intervention 01/2020
1	Drug Therapy (Chemotherapy) 08/2014
1	Lasers (Laser) 07/2011